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To the Editor,
In a recent article, Taylor et al 1 have shown that C-Reactive Protein (CRP), per se, does not activate endothelial cells; rather, lipopolysacchride (LPS) and azide were responsible for the observed cellular activation. We would like to provide our data to further support the conclusion by Taylor and colleagues.
We have tested Ͼ10 batches of commercial human CRP preparations from 3 companies (Calbiochem, TriChem, and Sigma). Human saphenous vein endothelial cells (HUVECs, passages 3 to 5) were grown in MCDB-131 medium supplemented with 10% FBS. The cells were incubated with CRP for 24 hours, and the culture supernatants were assessed for IL-6 using the IL-6 ELISA kit (R&D). It was reported previously that CRP induced IL-6 production from HUVECs. 2 Our main observations are summarized as follows.
All recombinant human CRP (rCRP, Escherichia coli-derived) that we tested stimulated HUVECs to secrete IL-6 significantly, and all of these CRP preparations contained endotoxin (10 to 100 EU/mL) as measured by the LAL gel clot assay (Associates of Cape Cod). 3 The CRP-induced IL-6 secretion was correlated with the level of endotoxin contamination. Moreover, all these CRP preparations lost their ability to activate HUVECs after endotoxin was removed using a detoxi-gel column (Pierce). Furthermore, reintroducing LPS to CRP to a level equivalent to that presented before purification re-established the ability of CRP to stimulate HUVECs (Figure) . The CRP preparation purified from human plasma (Sigma) had low endotoxin levels (Ͻ0.31 EU/mL) and did not stimulate HUVECs (up to 100 g/mL of CRP). However, the CRP purified from human plasma and purchased from TriChem contained high levels of endotoxin (160 EU/mL) and caused a robust production of IL-6 (up to 5 ng/mL). Analysis by size exclusion chromatography and SDS-PAGE suggest that removal of LPS by detoxi-gel column did not result in change in CRP structurally. Taken together, endotoxin contamination plays a confounding role in the interpretation of biologic actions previously attributed to CRP. 
-L.Y) and Protein Chemistry (P.J.M., G.F.S., K.O.J.) GlaxoSmithKline Pharmaceuticals, King of Prussia, Penn
Role of LPS in CRP-induced IL-6 production from HUVECs in vitro. HUVECs were incubated for 24 hours with medium alone; rCRP (recombinant human CRP, 1 mg/mL, Calbiochem) containing endotoxin 80 EU/mL; p-rCRP (LPS-removed rCRP, LPS Ͻ0.31 EU/mL); or p-rCRP plus LPS. The final concentrations of CRP are indicated in the figure. Supernatants were harvested and analyzed for IL-6. Results are expressed as meanϮSEM of experiments performed in triplicate samples. **PϽ0.01 vs basal (medium alone). EU indicates endotoxin unit.
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